"Leukocyte Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.
| Descriptor ID |
D007960
|
| MeSH Number(s) |
C15.378.553
|
| Concept/Terms |
Leukocyte Disorders- Leukocyte Disorders
- Disorder, Leukocyte
- Disorders, Leukocyte
- Leukocyte Disorder
|
Below are MeSH descriptors whose meaning is more general than "Leukocyte Disorders".
Below are MeSH descriptors whose meaning is more specific than "Leukocyte Disorders".
This graph shows the total number of publications written about "Leukocyte Disorders" by people in this website by year, and whether "Leukocyte Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukocyte Disorders" by people in Profiles.
-
Shenoy AT, Wasserman GA, Arafa EI, Wooten AK, Smith NMS, Martin IMC, Jones MR, Quinton LJ, Mizgerd JP. Lung CD4+ resident memory T cells remodel epithelial responses to accelerate neutrophil recruitment during pneumonia. Mucosal Immunol. 2020 03; 13(2):334-343.
-
Huang J, Dahl DM, Dong L, Liu Q, Cornejo K, Wang Q, Wu S, Feldman AS, Huang Y, Xue W, Wu CL. Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma. Biomed Res Int. 2015; 2015:891045.
-
Santoni M, Buti S, Conti A, Porta C, Procopio G, Sternberg CN, Bracarda S, Basso U, De Giorgi U, Rizzo M, Derosa L, Ortega C, Massari F, Milella M, Bersanelli M, Cerbone L, Muzzonigro G, Burattini L, Montironi R, Santini D, Cascinu S. Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy. Target Oncol. 2015 Dec; 10(4):517-22.